The initial critical challenge in B-cell development is the creation of B cells with an extensive repertoire—billions of B-cell receptor specificities—capable of responding to virtually any foreign element entering the body. The diversity of antibodies, arising from gene rearrangements, junctional diversification, and various combinations of heavy and light chains, is further enhanced by the daily production of millions of new B cells. Unnecessary B cells are replaced by new ones generated in the bone marrow through hematopoiesis and B-cell development processes. Progression through hematopoietic stages, commitment to the lymphoid lineage, and early B-cell development in the bone marrow, leading to the formation of immature B cells, is regulated by transcription factor networks. Of particular significance is the E2A → EBF1 → PAX5 transcription factor cascade, a feed-forward regulatory mechanism where PAX5 activates the genes defining the B lymphocyte phenotype, which remains unchanged until antigen and other signals prompt differentiation into antibody-secreting plasma cells. This intricate transcription factor network is influenced by, and influences, numerous epigenetic modifications controlling the gene transcription and protein expression unique to each stage. The precise and successful recombination of heavy and light-chain genes is integral to, and sometimes drives, the progression through B-cell developmental stages, with checkpoints ensuring proper rearrangements that yield functional BCRs. Following V-DJ recombination, the µ heavy chain undergoes testing to confirm its ability to pair and associate with the surrogate light-chain polypeptide; if successful, the resulting pre-BCR provides the necessary signals for further development.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related